Indomethacin (IND) is a widely used nonsteroidal anti-inflammatory drug. Its clinical pharmacological effect is known to be diminished by co-administration of aspirin (ASP).
Indomethacin (IND) is a widely used nonsteroidal anti-inflammatory drug. Its clinical pharmacological effect is known to be diminished by co-administration of aspirin (ASP). 1, 2) Its pharmacokinetic interaction with ASP is generally not well understood, although it is reported that a single or multiple doses of ASP decreased the plasma concentration of IND, but not of ASP, in both healthy volunteers 3) and rheumatic patients given both IND and ASP orally.
2) Chronic treatment with ASP was found to decrease the gastrointestinal absorption, to enhance the biliary clearance and the enterohepatic circulation, and suppress the renal clearance of IND. 3) With regard to the serum concentration related to the interactions between ASP and IND, these drugs bind to the same site of human serum albumin, 85 and Ͼ90%, respectively. [4] [5] [6] This indicates that IND is displaced by ASP competitively in sites I and II, so that the concentration of unbound IND becomes higher in the serum than when IND is administered alone. If the unbound IND were subjected to glucuronidation by uridine 5Ј-diphosphate (UDP)-glucuronosyltransferases (UGTs) and/or hydroxylation by cytochrome P450s (CYPs), followed by excretion into the feces and urine, the pharmacological activities of IND would be diminished. Therefore, it is necessary to examine the metabolic interaction of both drugs.
ASP was biotransformed to salicylic acid (SA) in the serum, liver and kidney, and the salicylate (SA) was further metabolized to the conjugates with glucuronic acid and glycine, and to the hydroxylated metabolites, 2,3-dihydroxy-, 2,5-dihydroxy-and 2,3,5-trihydroxybenzoic acids. 7, 8) The 5-hydroxylation of SA was performed by human-CYPs 2E1 and 3A4, 9) and rat-CYP2E1. 9 ,10) The 3-hydroxylation was due to rat CYP3A and CYP2B 11) but was not CYP dependent in human, 9) whereas IND was metabolized to its Odesmethyl-(DMIND) and N-des-p-chlorobenzoyl-IND (5-methoxy-2-methyl-3-indoleacetic acid; MMIAA) and their glucuronides.
12) The O-demethylation of IND was catalyzed mainly by CYP2C9, and minimally by CYPs 1A2 and 2D6 in human liver microsomes. 13 ) DMIND and IND were glucuronidated in the liver microsomes 14, 15) and kidney. 16, 17) Although these metabolites were also found in rat bile, feces and urine, 18) a high percentage of IND and small amounts of DMIND and MMIAA were found in the bile. 18 ) Taking these observations together, this metabolic evidence is not competitive and does not support a drug-drug interaction in which concomitant ASP can be claimed to reduce the pharmacological activity of IND. Therefore, crucial to the interaction is whether ASP/SA induce(s) a higher permeability of IND into the organs and tissues and/or a higher metabolism of IND.
MATERIALS AND METHODS
Chemicals ASP, IND, des-p-chlorobenzoyl-IND MMIAA, SA, and uridine 5Ј-diphosphoglucuronic acid (UDPGA) were purchased from Sigma-Aldrich Com./Japan. Carboxylesterase (from hog liver) was from Boehringer Mannheim GmbH. Benzbromarone, bovine serum albumin (BSA), 5,5-dithio-bis (2-nitrobenzoic acid) (DTNB) and ketoprofen were from Wako Pure Chemicals (Tokyo). Other reagents and other assay kits were also from Wako Pure Chemicals (Tokyo).
Experimental Animals Male Wistar rats (250-300 g) were obtained from Charles River Laboratories, Inc. (Japan). The animals were housed in cages under controlled conditions of temperature and humidity, and were subjected to a 12 h light/dark cycle. The rats were fed an Oriental laboratory diet and water ad libitum. After acclimatization for one week, the animals were divided into two groups for experiments on rat red blood cells (RBCs) and hepatocytes.
Incubation of IND and RBCs with/without the Existence of ASP Blood samples (about 5 ml) were collected from the jugular vein and subjected to biochemical examination. Erythrocytes (RBCs) from the control rats were isolated from the plasma by centrifugation at 1000ϫg for 10 min and washed three times with saline (15 ml), respectively. A suspension (20 ml) of the washed RBCs (9.0ϫ10 6 /ml) was incubated with the respective ASP and IND (each at 0, 6, 12, and 24 fmol/RBC) in 143 mM phosphate buffer (PB) which in-cluded 5.5 mM glucose (2 ml, pH 7.4) or 5.8 mM phosphate buffer (PBS) which included saline and 5.5 mM glucose (2 ml, pH 7.4) at 37°C for 2 h.
Osmotic pressures of the drug in PB or PBS were adjusted at 300.5Ϯ2.5 mOsm/kg using a Crytomatic Osmometer Model 3CII (Advanced Instruments).
PB was used for low pKa drugs because of its higher buffer action and PBS was used for the transport of drugs because human and rat sera contain chloride ion of 99 to 109 meq/l, corresponding to saline.
The incubation mixture was centrifuged at 1000ϫg for 10 min to give a sediment and supernatant fractions. The supernatants were subjected to measurement of hemoglobin (Hb) concentration. The sediment was lysed with distilled water (500 ml) and gave a lysed solution and ghost pellets. The lysed solution was used to measure levels of ATP, glutathione (GSH) and Hb.
Incubation of ASP or SA with RBCs A suspension (20 ml) of the washed RBCs (9.0ϫ10 6 /ml) was incubated with ASP or SA (each at 25 fmol/RBC) in PB (2 ml) for 10, 30, 60, 90, and 120 min. The incubation mixture was treated as described above.
Effects of ASP on Concentration of Benzbromarone in RBC A suspension (100 mlϫ5) of the washed RBCs described above was incubated with ASP (10 fmol/RBC) and benzbromarone (10 fmol/RBC) in PB (4 mlϫ5) at 37°C for 2 h. After treatment as above, the sediment was lysed with distilled water (500 ml) and separated from the ghost to give a lysed solution, which was then freeze-dried and extracted with methanol (1 mlϫ3). The methanol extract was chromatographed on a silicagel plate (Kieselgel F254) using benzene : methanol (8 : 2). The developed band was extracted with ethyl acetate and levels of the extracted drug were measured from the respective calibration curves at 230 nm for ASP, and 273 nm for benzbromarone, respectively.
Incubation of IND with Rat Plasma or Carboxylesterase The above plasma (0.2 ml) or carboxylesterase (13 U) and ASP or IND (10, 20 and 50 ml of 0.1 mg IND/ml) in PB (2 ml) were incubated at 37°C for 60 min. The reaction mixture was centrifuged using centricut (W-10) at 4400 rpm for 40 min to give a filtrate. The compounds in the filtrate were identified with authentic specimen on TLC and HPLC. TLC conditions: plate, silica gel 60-F-254; developing solvents, benzene : dioxane : acetic acid (30 : 5 : 1 v/v) and HPLC described below.
Hematological Examination of the RBCs The number of RBC and mean corpuscular volume (MCV) were measured using a Sysmex M-2000 equipped with a SysmexDA-1000 (Sysmex Co., Ltd., Japan).
Measurement of ATP, GSH, and Hb ATP assay: A lysed solution of the RBCs was centrifuged at 960ϫg for 15 min followed by recentrifugation at 8000ϫg for 10 min at 4°C to give a supernatant. ATP levels in the supernatant were assayed using a TOA ATP Analyzer AF 100 (TOA Electronics, Ltd.) equipped with a TOA Auto Dispenser DF 10 (by the luciferin-luciferase method).
GSH assay: Each of samples (0.2 ml) was added to a solution (0.3 ml) of 1.67 g of metaphosphoric acid, 0.2 g of EDTA-Na 2 and 30 g of NaCl in 100 ml of water. The mixture was allowed to stand for 5 min and centrifuged at 9000ϫg for 10 min at 4°C. The supernatant (0.2 ml) was diluted with 0.5 M sodium phosphate buffer (0.6 ml, pH 9.15). A solution of 0.1% o-phthalic aldehyde in methanol (0.1 ml) was added to the diluted solution and the fluorescence was determined after 1 min at 420 nm (emission) and 350 nm (excitation) using a Hitachi F-3010 Fluorescence Spectrophotometer, according to two known methods. 19, 20) Hb assay: The levels in Hb were determined using an assay kit, Hemoglobin B Test Wako (by sodium lauryl sulfate method, Wako Pure Chemicals, Japan), respectively.
Preparation of Rat Liver Microsomes The animals were killed by decapitation, and individual liver microsomes were prepared by the usual method: The liver was homogenized with 0.25 M sucrose (9 vol.) to give a supernatant by centrifugation at 960ϫg for 10 min and then 9000ϫg for 20 min, and the supernatant was centrifuged at 105000ϫg for 60 min to give a pellet. The microsomal pellet was suspended in 0.1 M potassium phosphate buffer (pH 7.4) and stored at Ϫ30°C until use.
Microsomal Protein Assay Microsomal protein concentration was determined by the method of Bradford 21) with a Bio-Rad Protein Assay Kit. Absorbance was measured at 595 nm with a Hitachi Model U-2001 spectrophotometer.
Determination of Total CYP Contents Total microsomal CYP content was determined from the sodium di-thionite-reduced carbon monooxide difference spectrum using a molar extinction coefficient of between 450 nm and 490 nm: 22) The liver microsomal pellet suspension was adjusted to 1.0 mg/ml by dilution with a solution of 20% glycerol, 1 mM EDTA, 0.1 M potassium phosphate buffer (pH 7.25) and 0.2% Emulgen 913 (Kao Co. Ltd., Tokyo) and the diluted suspension was divided into a sample and reference. The sample was subjected to carbon monooxide gas for 1 min, and the sample and reference both were treated with di-thionite to give a different spectrum OD .
Incubation of IND or MMIAA with/without Addition of ASP in the Microsomes
In the NADPH-generating system; the reaction mixture contained 0.1 M potassium phosphate buffer (pH 7.4), IND (0, 0.25, 0.50, and 1 mM), an NADPH-generating system (0.33 mM b-NADP ϩ , 8 mM G-6-P, 0.4 unit/ml G-6-P dehydrogenase, and 6 mM MgCl 2 ), and a 250 mg microsomal protein (0.46 nmol CYP/mg protein) in a final volume of 250 ml. The mixture was incubated at 37°C for various periods (0, 10, 30, 60, 90, and 120 min) and the reaction was stopped by addition of methanol. Metabolites were extracted with ethyl acetate for examination by HPLC.
In the UDPGA system; the reaction mixture contained 100 mM IND, or 100 mM MMIAA, 50 mM Tris/HCl (pH 7.4), 10 mM MgCl 2 , 0.05% Brij, 10 mM D-succharic 1,4-lactone monohydrate, and 250 mg microsomal protein in a final volume of 250 ml. The mixture was allowed to stand for 2 h on ice and then preincubated for 10 min at 37°C. Three mM of UDPGA was added and the mixture was incubated for various periods (0, 30, 60, 90, and 120 min), before being stopped by the addition of methanol.
HPLC Analysis of ASP, ASP-Glucuronide, IND, INDGlucuronide, MMIAA, and SA The above incubation mixture was diluted 1000-fold with water. To the mixture was added an internal standard, 10 ml of 2.5 mM ketoprofen, and then methanol (1.0 ml) was mixed in. After centrifugation at 960ϫg for 10 min, the methanol extracted material was dried under N 2 gas, dissolved in a solution (200 ml) of methanol : water (2 : 1) and centrifuged at 960ϫg for 10 min to give a supernatant. The supernatant (100 ml) was subjected to HPLC analysis on a Shimadzu HPLC system Model CLASS-VP equipped with LC-10AT pump, SPD-10AVP detector, SIL-10AxL autosampler, CTO10A open column and DGU-4A degassor. The following HPLC conditions were employed: the mobile phase was a solution of methanol : acetonitrile : acetic acid : water (55 : 35 : 10 : 1). The HPLC system consisted of an analytical TSK-gel ODS-80Ts column (particle size 5 mm, 4.6 mmϫ15.0 mm I.D., Tosoh, Japan) . The flow rate was 1 ml/min, and the column eluate was monitored with a UV detector at 260 nm.
ASP and SA were measured using a mobile solution of acetic acid : methanol : water (2 : 50 : 48, pH 2.7) and column, ODS-120T.
Preparation and Incubation of Hepatocytes Hepatocytes were isolated from adult male Wistar rats (body weight 250-300 g), according to the procedure described by Shimaoka et al. 23) : Briefly, the liver was first perfused in situ through the portal vein with 200 ml (30 ml/min) of Ca 2ϩ -free Hanks' solution containing 5 mM EGTA at 37°C for a few minutes, followed by perfusion with 400 ml (30 ml/min) of 0.05% collagenase solution. The perfused liver was excised and dispersed in cold Eagle's minimum essential medium (MEM) and the resulting cell suspension was filtered through a double layer of gauze. The liver cells were separated into two fractions, parenchymal hepatocytes and nonparenchymal cells (NPC), by differential centrifugation at 50ϫg for 1 min. The precipitated cells were washed three times with MEM to use as hepatocytes. Cell viability was determined by a trypan blue dye exclusion. The cells were plated at a density of 1ϫ10 5 cell/0.2 ml/cm 2 in wells of Falcon culture dishes (60ϫ15 mm) coated with collagen (Nitta Gelatin Co., Osaka) in 1 ml of WE medium supplemented with 5% calf serum. After incubation for 3 h for cell attachment, the medium and dead cells were removed. To the attached cells were added 1 ml of fresh medium supplemented with 10 Ϫ9 M insulin, 10 Ϫ9 M dexamethasone, and 30 mg/l kanamycin, and the mixture was incubated for 12 h to use in the experiment. After removal of insulin, dexamethasone and kanamycin, and washing with WE medium, the cells were incubated with 50 mM or 100 mM IND with/without addition of 50 mM ASP or BSA in WE (total volume 4 ml) at 37°C under 95% O 2 -5% CO 2 for 3, 6, 12 and 24 h. The incubation was stopped by addition of methanol. Part of the metabolites was extracted with ether, ethyl acetate, or methanol, and the extracts were examined by HPLC.
Measurement of Lactate Dehydrogenase (LDH) in the Hepatocytes LDH assay was performed using a LDH assay kit (LDH-UV test Wako, Wako Pure Chemicals) in the hepatocytes after incubation with a maximum concentration of each drug, (50 mM) and concomitant drugs (each 50 mM) with/without the co-existence of BSA (50 mM) for 3, 6, 12 and 24 h. (Fig. 1) .
Effects of ASP/SA on Permeability of IND into RBC Levels of IND in the RBC were examined with/without the addition of ASP and/or BSA (Figs. 1, 2) . When the same equivalent of ASP was concomitantly added to RBCs with IND, ASP/SA led to an increase in the levels of IND in the RBC in a dose-dependent manner compared with IND alone, showing about 9-fold at a 6 fmol dose without the existence of BSA, and about 2-fold at 12 and 24 fmol/RBC in both PB and PBS, respectively (Fig. 1) . The dose dependent increase of IND was also observed when BSA was present, at 1/10 of the levels without BSA (Fig. 2) , but the addition of ASP showed a higher constant increase in IND (about 10-to 3-fold at 6 to 24 fmol/RBC) compared with the respective IND level) (Fig. 2) . The ratios of PBS to PB for the intracorpuscular levels in IND were similar, irrespective of the addition of ASP.
Effects of ASP on Concentration of Benzbromarone in RBC Benzbromarone and salicylate were excreted from RBCs by a multidrug resistance protein-1 (MRP-1). 26) To determine whether ASP inhibited the excretion of benzbromarone from RBC, RBC was incubated with ASP and benzbromarone, respectively, and their levels following incubation were 1.61Ϯ0.08 fmol/RBC and 0.57Ϯ0.09 fmol/RBC within RBC, respectively. The level of benzbromarone under the concomitance of ASP was 0.84Ϯ0.04 fmol/RBC, accompanied with 1.10Ϯ0.40 fmol/RBC of ASP. ASP increased the level of benzbromarone to 150%, accompanied by both a de-crease of ASP to 68% and the existence of SA on TLC.
Hydrolysis of IND in Rat RBC and the Plasma, and by Carboxylesterase IND was hydrolyzed to MMIAA within the RBC and in the plasma, and by carboxylesterase, respectively. The hydrolysis of IND in RBCs was not affected by concomitance of ASP, although about 3.4 amol MMIAA/RBC was produced from IND within the RBC with no existence of BSA, respectively.
On incubation of MMIAA and RBCs in PB or PBS, irrespective of the existence of BSA, MMIAA was not observed in the cytoplasm, indicating that MMIAA did not penetrate into the RBC.
Metabolism of IND by Rat Liver Microsomes and Identification of the Metabolites Transformation of IND to
DMIND by the microsomes was not observed in the presence of an NADPH-generating system (the data not shown), but the existence of UDP-glucuronic acid induced a production of the two metabolites at a retention-time (RT) of 5.3 and 21 min on HPLC. Levels in the 21 min-metabolite showed linearly increased curves in an incubation-time dependent manner, but the 5.3 min-metabolite did not show this (Fig. 3) . When the RTs of the metabolites were compared with those of IND at 50.6 min, and with MMIAA at 5.3 min on HPLC, respectively, the 5.3 min-metabolite was identified as MMIAA. The 21 min-metabolite was different from MMIAA-glucuronide (at 3.1 min) and was identified as an ester-type IND-glucuronide because its hydrolysis product by b-glucuronidase and carboxylesterase was identified to have 678 Vol. 26, No. 5 Effect of ASP/SA on Glucuronidation of IND in the Microsomes Since the glucuronidation of IND showed increased curves in an incubation-time dependent manner (Fig.  3) , the effects of ASP/SA on the glucuronidation were examined at the 90 min-incubation. The glucuronidation decreased to 84% (3.05Ϯ0.34 mM), 51.4% (1.87Ϯ0.51 mM, pϽ0.001), and 25.7% (0.94Ϯ0.34 mM, pϽ0.005) at 1/10, 1/2, and 1 equvalent mol ratio between ASP and IND, respectively, compared with that of IND alone (3.64Ϯ0.54 mM) (Fig. 4) . did not show the existence of DMIND on HPLC when compared with the retention-time under the conditions reported by Nakajima et al. 13) When the hepatocytes were incubated with 50 mM IND for 3, 6, 12 and 24 h, the presence of two metabolites was observed at RTs 5.3 min and 21 min, and these were identified as MMIAA and IND-glucuronide, respectively. The IND levels showed a greater decrease at 3 hincubation, and then an increase (Fig. 5a) , being in inverse proportion between a decrease of IND and a production of IND-glucuronide (Figs. 5b, c) , IND-glucuronide, in contract, showed a decrease from 3 to 6 h and constant production from 6 to 24 h without the addition of ASP, but the addition increased the levels of IND glucuronide from 3 to 24 h in an incubation time dependent manner, although the production of MMIAA showed no significant difference with or without ASP addition. Other metabolites than IND, IND-glucuronide, and MMIAA had retention-times ranging up to 3 min on HPLC, and their peaks were superimposed with solvent ones. Concentrations of the metabolites calculated by deduction of the solvent concentration were 42.2Ϯ6.30 mM (corresponding to about 84% of the total IND, 50 mM) from 3 to 24 h without ASP, and 72.4Ϯ5.69 mM (about 72% of the total drugs, 50 mM ASP and 50 mM IND). This suggested that the remainder, 16 and 28%, obtained by deduction of 84 and 72% from the total drug(s) concentrations might be lost from the medium into the hepatocytes, respectively.
When The reaction mixture contained 100 mM IND, ASP (0, 10, 50, and 100 mM), 50 mM Tris/HCl (pH 7.4), 10 mM MgCl 2 , 0.05% Brij, 10 mM D-succharic 1,4-lactone monohydrate, and 250 mg microsomal protein. The mixture (250 ml) was allowed to stand for 2 h on ice and then preincubated for 10 min at 37°C. 3 mM UDPGA was added and the mixture was incubated for 90 min. A part of ASP was hydrolyzed to SA under this condition. The levels of IND glucuronide were determined by HPLC and represented as the equivalent moles.
ASP/SA increased the loss to about 50%, corresponding to (150Ϫ75.6)/150 mMϫ100.
Effects of BSA showed that the bound IND did not penetrate the hepatocytes (Fig. 6 ) and the unbound IND was metabolized to IND-glucuronide with significant difference, but MMIAA was not.
When the hepatocytes (5ϫ10 6 cells) were incubated with 50 and 100 mM IND for 3, 6, 12 and 24 h, LDH activities in the medium showed no change compared with the controls, irrespective of concomitant 50 mM ASP and/or 50 mM BSA. remain questions of whether ASP/SA can competitively inhibit glucuronidation of IND by any family of UGT using human and rat microsomes, whether ASP/SA inhibits excretion of IND from the hepatocytes, or whether the unmetabolized IND is excreted to the bile from the liver.
Further work is in progress to find solutions to these questions.
